The search for a unified theory of coagulation and inflammation

Cellular and Molecular Life Sciences

Volumn 61, Issue 21, 2004, Pages 2744-2749

  Veldman, A ^a   Fischer, D ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Coagulation; Inflammation; Model; Signaling; Tissue factor

Indexed keywords

ANTICOAGULANT PROTEIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 7; FIBRIN; FIBRINOGEN; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; MATRIX PROTEIN; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C; PROTEINASE ACTIVATED RECEPTOR 2; PROTHROMBIN; THROMBIN; VON WILLEBRAND FACTOR;

APOPTOSIS; BLOOD CLOTTING; ENZYME ACTIVATION; ENZYME DEGRADATION; FIBRINOLYSIS; GENE MUTATION; GENETIC PREDISPOSITION; GRANULOCYTE; HEMOPHILIA; HEMOSTASIS; HUMAN; INFLAMMATION; NEMATODE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTEIN EXPRESSION; PROTHROMBIN TIME; REVIEW; SEPSIS; SEQUENCE HOMOLOGY; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ANIMALS; BLOOD COAGULATION; COAGULANTS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; SKIN;

EID: 11144310604     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4106-z     Document Type: Review

References (34)

1. Davie E. W. and Ratnoff O. D. (1964) Waterfall sequence for intrinsic blood clotting. Science 145: 1310-1312
2. MacFarlane R. G. (1964) An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202: 498-499
3. Hoffman M. and Monroe D. M. III. (2001) A cell-based model of hemostasis. Thromb. Haemost. 85: 958-965
4. Aras O., Shet A., Bach R. R., Hysjulien J. L., Slungaard A., Hebbel R. P. et al. (2004) Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 103: 4545-4553
5. Nieuwland R., Berckmans R. J., McGregor S., Boing A. N., Romijn F. P., Westendorp R. G. et al. (2000) Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95: 930-935
6. Jonge E. de, Dekkers P. E., Creasey A. A., Hack C. E., Paulson S. K., Karim A. et al. (2000) Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood 95: 1124-1129
7. Jilma B., Marsik C., Mayr F., Granniger M. T., Taylor F. B. Jr, Ribel M. C. et al. (2002) Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans. Clin. Pharmacol. Ther. 72: 403-410
8. Geisbert T. W., Hensley L. E., Jahrling P. B., Larsen T., Geisbert J. B., Paragas J. et al. (2003) Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet 362: 1953-1958
9. Szasz R. and Dale G. L. (2003) COAT platelets. Curr. Opin. Hematol. 10: 351-355
10. Versteeg H. H. (2004) Tissue factor as an evolutionary conserved cytokine receptor: implications for inflammation and signal transduction. Semin. Hematol. 41(Suppl 1): 168-172
11. Cunningham M. A., Romas P., Hutchinson P., Holdsworth S. R. and Tipping P. G. (1999) Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 94: 3413-3420
12. Versteeg H. H., Spek C. A., Richel D. J. and Peppelenbosch M. P. (2004) Coagulation factors VIIa and Xa inhibit apoptosis and anoikis. Oncogene 23: 410-417
13. Miller D. L., Welty-Wolf K., Carraway M. S., Ezban M., Ohio A., Suliman H. et al. (2002) Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 26: 650-658
14. Bono F., Schaeffer P., Herault J. P., Michaux C., Nestor A. L., Guillemot J. C. et al. (2000) Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2. Arterioscler. Thromb. Vasc. Biol. 20: E107-E112
15. Shimizu T., Nishihira J., Watanabe H., Abe R., Honda A., Ishibashi T. et al. (2004) Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cells. J. Biol. Chem. 279: 13729-13737
16. McLean K., Schirm S., Johns A., Morser J. and Light D. R. (2001) FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834. Thromb. Res. 103: 281-297
17. Minnema M. C., Chang A. C., Jansen P. M., Lubbers Y. T., Pratt B. M., Whittaker B. G. et al. (2000) Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli. Blood 95: 1117-1123
18. Hoffmann J. N., Vollmar B., Laschke M. W., Inthorn D., Kaneider N. C., Dunzendorfer S. et al. (2002) Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms. Thromb. Haemost. 88: 242-252
19. Warren B. L., Eid A., Singer P., Pillay S. S., Carl P., Novak I. et al. (2001) Caring for the critically ill patient: high-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286: 1869-1878
20. Riewald M., Petrovan R. J., Donner A., Mueller B. M. and Ruf W. (2002) Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296: 1880-1882
21. White B., Schmidt M., Murphy C., Livingstone W., O'Toole D., Lawler M. et al. (2000) Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. Br. J. Haematol. 110: 130-134
22. Hirose K., Okajima K., Taoka Y., Uchiba M., Tagami H., Nakano K. et al. (2000) Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann. Surg. 232: 272-280
23. Isobe H., Okajima K., Uchiba M., Mizutani A., Harada N., Nagasaki A. et al. (2001) Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 104: 1171-1175
24. Shua F., Kobayashia H., Fukudomeb K., Tsuneyoshib N., Kimotob M. and Teraoa T. (2000) Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner. FEBS Lett 477: 208-212
25. Kerlin B. A., Yan S. B., Isermann B. H., Brandt J. T., Sood R., Basson B. R. et al. (2003) Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood 102: 3085-3092
26. Bernard G. R., Vincent J. L., Laterre P. F., LaRosa S. P., Dhainaut J. F., Lopez-Rodriguez A. et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344: 699-709
27. White B., Schmidt M., Murphy C., Livingstone W., O'Toole D., Lawler M. et al. (2000) Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. Br. J. Haematol. 110: 130-134
28. Schiffer R., Klein B., Klosterhalfen B. and Zwadlo-Klarwasser G. (1999) The contact of human macrophages with extracellular matrix proteins selectively induces expression of pro inflammatory cytokines. Pathobiology 67: 233-235
29. Roman J., Ritzenthaler J. D., Perez R. L. and Roser S. L. (1999) Differential modes of regulation of interleukin-1beta expression by extracellular matrices. Immunology 98: 228-237
30. Blomback B., Carlsson K., Fatah K., Hessel B. and Procyk R. (1994) Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. Thromb. Res. 75: 521-538
31. Collet J. P., Park D., Lesty C., Soria J., Soria C., Montalescot G. et al. (2000) Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler. Thromb. Vasc. Biol. 20: 1354-1361
32. Balding J., Healy C. M., Livingstone W. J., White B., Mynett-Johnson L., Cafferkey M. et al. (2003) Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun. 4: 533-540
33. Holmes C. L., Russell J. A. and Walley K. R. (2003) Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 124: 1103-1115
34. Lim B. C., Ariens R. A., Carter A. M., Weisel J. W. and Grant P. J. (2003) Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet 361: 1424-1431